BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 24519943)

  • 1. Oligomerization of the Nrdp1 E3 ubiquitin ligase is necessary for efficient autoubiquitination but not ErbB3 ubiquitination.
    Printsev I; Yen L; Sweeney C; Carraway KL
    J Biol Chem; 2014 Mar; 289(12):8570-8. PubMed ID: 24519943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-transcriptional mechanisms contribute to the suppression of the ErbB3 negative regulator protein Nrdp1 in mammary tumors.
    Ingalla EQ; Miller JK; Wald JH; Workman HC; Kaur RP; Yen L; Fry WH; Borowsky AD; Young LJ; Sweeney C; Carraway KL
    J Biol Chem; 2010 Sep; 285(37):28691-7. PubMed ID: 20628057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of Nrdp1 enhances ErbB2/ErbB3-dependent breast tumor cell growth.
    Yen L; Cao Z; Wu X; Ingalla ER; Baron C; Young LJ; Gregg JP; Cardiff RD; Borowsky AD; Sweeney C; Carraway KL
    Cancer Res; 2006 Dec; 66(23):11279-86. PubMed ID: 17145873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuregulin-induced ErbB3 downregulation is mediated by a protein stability cascade involving the E3 ubiquitin ligase Nrdp1.
    Cao Z; Wu X; Yen L; Sweeney C; Carraway KL
    Mol Cell Biol; 2007 Mar; 27(6):2180-8. PubMed ID: 17210635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantity control of the ErbB3 receptor tyrosine kinase at the endoplasmic reticulum.
    Fry WH; Simion C; Sweeney C; Carraway KL
    Mol Cell Biol; 2011 Jul; 31(14):3009-18. PubMed ID: 21576364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nrdp1/FLRF is a ubiquitin ligase promoting ubiquitination and degradation of the epidermal growth factor receptor family member, ErbB3.
    Qiu XB; Goldberg AL
    Proc Natl Acad Sci U S A; 2002 Nov; 99(23):14843-8. PubMed ID: 12411582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ER structural protein Rtn4A stabilizes and enhances signaling through the receptor tyrosine kinase ErbB3.
    Hatakeyama J; Wald JH; Rafidi H; Cuevas A; Sweeney C; Carraway KL
    Sci Signal; 2016 Jun; 9(434):ra65. PubMed ID: 27353365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based mutagenesis of the substrate-recognition domain of Nrdp1/FLRF identifies the binding site for the receptor tyrosine kinase ErbB3.
    Bouyain S; Leahy DJ
    Protein Sci; 2007 Apr; 16(4):654-61. PubMed ID: 17384230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nrdp1S, short variant of Nrdp1, inhibits human glioma progression by increasing Nrdp1-mediated ErbB3 ubiquitination and degradation.
    Wu Y; Wang L; Bao H; Zou S; Fu C; Gong H; Gao Y; Tang Y; Yu R; Shi H
    J Cell Mol Med; 2016 Mar; 20(3):422-9. PubMed ID: 26612725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KITENIN functions as a fine regulator of ErbB4 expression level in colorectal cancer via protection of ErbB4 from E3-ligase Nrdp1-mediated degradation.
    Sun EG; Lee KH; Ko YS; Choi HJ; Yang JI; Lee JH; Chung IJ; Paek YW; Kim H; Bae JA; Kim KK
    Mol Carcinog; 2017 Mar; 56(3):1068-1081. PubMed ID: 27648936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nrdp1-mediated regulation of ErbB3 expression by the androgen receptor in androgen-dependent but not castrate-resistant prostate cancer cells.
    Chen L; Siddiqui S; Bose S; Mooso B; Asuncion A; Bedolla RG; Vinall R; Tepper CG; Gandour-Edwards R; Shi X; Lu XH; Siddiqui J; Chinnaiyan AM; Mehra R; Devere White RW; Carraway KL; Ghosh PM
    Cancer Res; 2010 Jul; 70(14):5994-6003. PubMed ID: 20587519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nrdp1 expression to predict clinical outcome and efficacy of adjuvant anthracyclines-based chemotherapy in breast cancer: A retrospective study.
    Jiao S; Liu W; Wu M; Peng C; Tang H; Xie X
    Cancer Biomark; 2015; 15(2):115-23. PubMed ID: 25519010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stabilization of the E3 ubiquitin ligase Nrdp1 by the deubiquitinating enzyme USP8.
    Wu X; Yen L; Irwin L; Sweeney C; Carraway KL
    Mol Cell Biol; 2004 Sep; 24(17):7748-57. PubMed ID: 15314180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An RBCC protein implicated in maintenance of steady-state neuregulin receptor levels.
    Diamonti AJ; Guy PM; Ivanof C; Wong K; Sweeney C; Carraway KL
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2866-71. PubMed ID: 11867753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nrdp1-mediated ErbB3 degradation inhibits glioma cell migration and invasion by reducing cytoplasmic localization of p27(Kip1).
    Shi H; Gong H; Cao K; Zou S; Zhu B; Bao H; Wu Y; Gao Y; Tang Y; Yu R
    J Neurooncol; 2015 Sep; 124(3):357-64. PubMed ID: 26088461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological and prognostic correlations of HER3 expression and its degradation regulators, NEDD4-1 and NRDP1, in primary breast cancer.
    Luhtala S; Staff S; Kallioniemi A; Tanner M; Isola J
    BMC Cancer; 2018 Oct; 18(1):1045. PubMed ID: 30367623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of ErbB3 and its binding partners in breast cancer progression and resistance to hormone and tyrosine kinase directed therapies.
    Hamburger AW
    J Mammary Gland Biol Neoplasia; 2008 Jun; 13(2):225-33. PubMed ID: 18425425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nrdp1-mediated degradation of the gigantic IAP, BRUCE, is a novel pathway for triggering apoptosis.
    Qiu XB; Markant SL; Yuan J; Goldberg AL
    EMBO J; 2004 Feb; 23(4):800-10. PubMed ID: 14765125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoubiquitination of BCA2 RING E3 ligase regulates its own stability and affects cell migration.
    Amemiya Y; Azmi P; Seth A
    Mol Cancer Res; 2008 Sep; 6(9):1385-96. PubMed ID: 18819927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nrdp1 inhibits growth of colorectal cancer cells by nuclear retention of p27.
    Lu H; Li H; Mao D; Zhu Z; Sun H
    Tumour Biol; 2014 Sep; 35(9):8639-43. PubMed ID: 24867101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.